NAD+ enhancers as therapeutic agents in the cardiorenal axis.

MLA

Marín-Blázquez, Mariano, et al. “NAD+ Enhancers as Therapeutic Agents in the Cardiorenal Axis.” Cell Communication & Signaling, vol. 22, no. 1, Nov. 2024, pp. 1–30. EBSCOhost, https://doi.org/10.1186/s12964-024-01903-4.

APA

Marín-Blázquez, M., Rovira, J., Ramírez-Bajo, M. J., Zapata-Pérez, R., & Rabadán-Ros, R. (2024). NAD+ enhancers as therapeutic agents in the cardiorenal axis. Cell Communication & Signaling, 22(1), 1–30. https://doi.org/10.1186/s12964-024-01903-4

Chicago

Marín-Blázquez, Mariano, Jordi Rovira, María José Ramírez-Bajo, Rubén Zapata-Pérez, and Rubén Rabadán-Ros. 2024. “NAD+ Enhancers as Therapeutic Agents in the Cardiorenal Axis.” Cell Communication & Signaling 22 (1): 1–30. doi:10.1186/s12964-024-01903-4.